Koyfin Home > Directory > Health Care > Kindred Biosciences > Total Debt / Capital

Kindred Biosciences Total Debt / Capital Chart (KIN)

Kindred Biosciences annual/quarterly Total Debt / Capital from 2019 to 2020.
  • Kindred Biosciences Total Debt / Capital for the quarter ending June 06, 2020 was $21m a 14.18% increase of 3m year over year
  • Kindred Biosciences Total Debt / Capital for the last 12 months ending June 06, 2020 was $21m a 14.18% increase of 3m year over year
Other Ratios Metrics:
  • Kindred Biosciences Other Liabilities for the quarter ending December 12, 2018 was $0m a -18.09% decrease of 0m year over year
View Chart On Koyfin

Quarterly KIN Total Debt / Capital Data

06/2020$21m
03/2020$27m
12/2019$22m
09/2019$18m
06/2019$2m
03/2019$1m

Annual KIN Total Debt / Capital Data

2019$22m